echocardiographic analysis, her pulmonary arterial systolic pressure had decreased to 34 mm Hg, and left ventricular ejection fraction had increased to 55%. There was only trace tricuspid valve regurgitation.
DISCUSSION
The patient described had parietal pericardial bovine bioprostheses in both the mitral and aortic valve positions for 77 months and during that period developed huge quantities of calcium on the cusps of the bioprosthesis in the aortic valve position and only small quantities of calcium on the cusps of the bioprosthesis in the mitral valve position. Because the closing pressure on the mitral bioprosthesis is usually about a third higher than that on the aortic bioprosthesis (peak left ventricular systolic pressure vs end-diastolic aortic pressure; normally approximately 120 vs 80 mm Hg), it might be expected that the degeneration of a bioprosthesis in the mitral position would be greater (more calcium and more tears) and more rapid than that of a bioprosthesis in the aortic position, but the opposite was the case in the patient described herein. Why might that be the case? Some possibilities include the following:
1. Parietal pericardial bovine bioprostheses are not the same as porcine aortic valve bioprostheses. The former are thicker and less flexible and possibly withstand the left ventricular peak systolic pressure and the aortic end-diastolic pressure more easily than the more delicate porcine aortic cusps. 2. The bovine bioprosthesis in the aortic position was defective and not properly prepared, whereas the one in the mitral position was not. 3. The febrile illness the patient had beginning 11 months after the initial cardiac operation could have been active infective endocarditis that affected the bioprosthesis in the aortic position but not the bioprosthesis in the mitral position. 4. Smaller bovine parietal pericardial bioprostheses calcify more rapidly and more extensively than do larger bovine pericardial bioprostheses. 5. The paravalvular leak in the mitral position and the absence of a leak in the aortic position provided a ''bypass shunt,'' diminishing the effect of the full force of the peak left ventricular systolic pressure on the bioprosthetic cusps in the mitral position.
None of these 5 possibilities can be proved or disproved, but this report might stimulate careful follow-up of similar patients to determine whether this distribution of calcium in the 2 left-sided bioprostheses is a pattern or an exception.
Is minimized extracorporeal circulation effective to reduce the need for red blood cell transfusion in coronary artery bypass grafting? Meta-analysis of randomized controlled trials Umberto Benedetto, MD, Emiliano Angeloni, MD, Simone Refice, MD, Fabio Capuano, MD, Massimo Goracci, MD, Antonino Roscitano, MD, and Riccardo Sinatra, MD, Rome, Italy
Perioperative red blood cell (RBC) transfusion is the single factor most consistently associated with an increased risk of postoperative morbid events after isolated coronary artery bypass grafting (CABG), and each unit of RBC transfused is associated with incrementally increased risk for adverse outcome. 1 Miniaturized extracorporeal circulation (mini-ECC) has been proposed to limit perioperative blood product use. Mini-ECC consists of a closed ECC system with no cardiotomy suction or venous reservoir. The rationale is to avoid air blood contact and minimize priming volume, thus reducing hemostasis alteration and intraoperative hemodilution. However, there is still controversy on whether such a strategy effectively reduces postoperative RBC transfusion, with some reports showing no evident benefit.
We conducted a meta-analysis on available randomized controlled trials (RCTs) to evaluate whether mini-ECC decreases the risk of postoperative RBC transfusion compared with conventional ECC in patients undergoing CABG.
MATERIALS AND METHODS
All RCTs comparing results of isolated CABG on mini ECC versus conventional ECC were identified using a 2 level search strategy. First, a public domain database (MEDLINE) was searched using a Web based search engine (PubMed). Second, relevant studies were identified through a manual search of secondary sources, including references of initially identified articles and a search of reviews and commentaries. The MED LINE database was searched from January 1966 to June 2008. MeSH key words included ''coronary artery bypass, mini extracorporeal circulation, mini cardiopulmonary bypass'' and ''randomized controlled trials.'' Stud ies considered for inclusion 2 12 met the following criteria: The design was an RCT, the patients were randomly assigned to mini ECC versus conven tional ECC CABG, and the study reported the postoperative RBC transfu sion rate or the amount of RBCs transfused per patient. When several RCTs reported on the same patient material, only the most recent article was included.
Two reviewers (U.B. and E.A.) independently abstracted the data. For each study, data regarding postoperative RBC transfusion rate were used to generate risk difference; data regarding the amount of RBCs transfused per patient were used to generate unbiased Hedges' g (<0 favors mini ECC; >0 favors conventional ECC). The 95% confidence intervals (CIs) were based on the asymptotic normality of the combined estimates. Publication bias was evaluated using the Begg and Mazumdar rank cor relation test. The pooled summary effect estimate was calculated by means of a fixed effect model. I 2 values were evaluated to assess hetero geneity, and a value greater than 50% was considered as indicative of heterogeneity. Meta regression (method of moments) was used to deal with the possibility of effect modification by patient risk profile (including age, female gender, number of grafts, ECC time) on the study estimates of effect size.
RESULTS
Our research identified 11 RCTs (including 1051 patients) that compared mini-ECC (n ¼ 520) with conventional ECC (n ¼ 531) CABG and that reported the RBC transfusion rate or the amount of RBC transfused per patient (Table 1) .
Pooled analysis showed that mini-ECC decreased the risk of RBC transfusion (risk difference,À0.10; 95% CI,À0.15 to À0.005; P < .0001) and the amount of RBC transfused per patient (Hedges' g, À0.25; 95% CI, À0.428 to À0.07; P ¼ .005) (Figure 1) .
Heterogeneity was absent for the RBC transfusion rate (I 2 ¼ 39%) but not for the amount of RBC transfused per patient (I 2 ¼ 78%). The number of grafts (b ¼ À0.09; P ¼ .01) and ECC time (b ¼ À0.005; P ¼ .01) but not age (P ¼ .42) and female gender (P ¼.96) influenced effect size estimates. No publication bias was found for postoperative RBC transfusion rate (P ¼ .50) and the amount of RBC transfused per patient (P ¼ .22).
DISCUSSION
Mini-ECC has been proposed to reduce postoperative RBC transfusion when compared with conventional ECC. However, among available RCTs, 7 of 11 failed to show a significant benefit. The present analysis, pooling data from RCTs, demonstrated an absolute risk reduction of RBC transfusion in patients receiving mini-ECC. In addition, this advantage was more evident as the complexity of procedure increased (higher number of grafts performed and prolonged ECC time). The lack of a significant benefit in some RCTs may be partially explained by their limited sample size. Because blood transfusion is reduced by approximately 30% with a lower priming volume, 2 the appropriate sample size should be at least 20 patients for each arm to obtain a study power of 0.80. Of note, 3 of 7 RCTs showing no advantages had only 10 patients for each arm. Abdel-Rahman and colleagues 3 observed no benefit in study with a large sample size. The authors used a heparin-uncoated minimized circuit that is no longer commercially available, and the latest mini-ECC systems with a fully heparin-coated closed circuit are associated with reduced hemostasis alterations secondary to blood contact with artificial surfaces. 
